Cannabis/Cannabidiol as Medicine: Are We There?

Presenter: Jag H. Khalsa, MS, PhD, Formerly, Chief Medical Consequences of Drug Abuse and Infections Branch, NIDA; Currently, Special Volunteer at NIDA/NIH.

Learning Objectives: The participants will learn about:

  • the current research available on medicinal cannabis/cannabinoids/cannabidiol and
  • the role of addiction physician/psychiatrist in dealing with medicinal cannabis/cannabidiol and their patients.


Collaborative Care Model for Integrating Mental Health and Substance Use Disorder Treatment

Presenter: Steve Daviss, MD, DFAPA, President of Fuse Health Strategies, and Lead Psychiatrist for Mindoula Health’s Collaborative Care Program

Learning Objectives:

  • Explain the Structure of Collaborative Care Services for Mental Health and Substance Use Disorders
  • Learn about the Evidence Base for Collaborative Care
  • List the CPT Codes for Collaborative Care
  • Identify Two Case Examples

Resource: Download Session Slide Deck

Patient Centered Care for Substance Use Disorders


  • Megan Buresh, MD, Assistant Professor, Division of Chemical Dependence, Johns Hopkins School of Medicine
  • Darius Rastegar, MD, Medical Director, Inpatient Chemical Dependence Unit, Johns Hopkins Bayview Medical Center and Associate Professor of Medicine at Johns Hopkins School of Medicine

Learning Objectives: At the conclusion of this session, attendees will be better able to:

  • Identify components of patient-centered care for substance use disorders
  • Define “treatment success” within patient-centered model
  • Describe model of low-threshold buprenorphine treatment
  • Discuss role of drug testing in patient-centered model

Resource: Download Session Slide Deck

What Every Clinician Needs to Know About Anxiety Disorder & OCD: Practical Tips

Presenter: Sally Winston, PsyD, Clinical Psychologist and Co-Director of the Anxiety and Stress Disorders Institute of Maryland

Learning Objectives: Participants will:

  • Increase diagnostic skills in the anxiety disorders and OCD.
  • Be introduced to the four factors that maintain and exacerbate anxiety and obsessive compulsive symptoms
  • Be introduced to the basic psychoeducational information that is the first building block of treatment 
  • Discard common myths about what helps and what doesn’t help panic attacks, phobias, excessive worry, and OCD.


 DEA Diversion Control: Who We Are and What We Do

Speaker: Justin Wood, Diversion Program Manager, Washington Field Division, Drug Enforcement Agency

Learning Objectives: Participants will be able to

  • Explain the scope of pharmaceutical diversion as relates to medical practices, particularly addiction medicine.
  • Describe the purpose of the Diversion Control Division within the Drug Enforcement Agency.
  • Summarize the roles and responsibilities of Diversion Investigators as it relates to enforcement in health care organizations

Resource: Download Slide Deck

Recent Research Greatest Hits 2019

Presented By: Marc Fishman, MD, FASAM, Medical Director, Maryland Treatment Centers, & Assistant Professor, Johns Hopkins University Department of Psychiatry

Learning Objectives: Participants will:

  • participate in critical consideration of research study data in reaching conclusions about results
  • use research results to inform new perspectives on clinical decision making